Physician profile
Yvette M Suarez
NPI 1750335543
$260,016.73
in general payments reported to CMS, 2019-2025
5 companies · $37K in 2025
The $37K reported for 2025 was more than what 99% of Pediatric Emergency Medicine (Emergency Medicine) providers received nationally (typical 2025 total: $57.68).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,262 · 2020: $9,823 · 2021: $10K · 2022: $49K · 2023: $81K · 2024: $70K · 2025: $37K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $165K · Consulting Fee: $9,520 · Food and Beverage: $8,395 · Travel and Lodging: $4,895 · Education: $67.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $165,100.00 |
| Consulting Fee | $9,520.00 |
| Food and Beverage | $8,394.68 |
| Travel and Lodging | $4,894.56 |
| Education | $67.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $183,495.80 | 2023-2025 | Botox, Kybella |
| Allergan, INC. | $64,532.62 | 2019-2022 | |
| Merz North America, INC. | $11,825.92 | 2019-2025 | Xeomin |
| Sanofi Pasteur INC. | $124.03 | 2024 | |
| Galderma Laboratories, L.P. | $38.36 | 2019-2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yvette Suarez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.